| Primary |
| Attention Deficit/hyperactivity Disorder |
35.9% |
| Product Used For Unknown Indication |
31.7% |
| Anxiety |
7.0% |
| Depression |
2.8% |
| Hypothyroidism |
2.8% |
| Adhd |
2.1% |
| Blood Cholesterol Increased |
2.1% |
| Blood Triglycerides Increased |
1.4% |
| Contraception |
1.4% |
| Disturbance In Attention |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Hypertension |
1.4% |
| Major Depression |
1.4% |
| Nervous System Disorder |
1.4% |
| Oestrogen Replacement Therapy |
1.4% |
| Somnolence |
1.4% |
| Accidental Drug Intake By Child |
0.7% |
| Add |
0.7% |
| Artificial Menopause |
0.7% |
| Asthenia |
0.7% |
|
| Product Substitution Issue |
14.3% |
| Weight Decreased |
14.3% |
| Suicidal Ideation |
10.2% |
| Off Label Use |
8.2% |
| Prescribed Overdose |
8.2% |
| Tic |
6.1% |
| Product Quality Issue |
4.1% |
| Somnolence |
4.1% |
| Suicidal Behaviour |
4.1% |
| Therapeutic Response Unexpected |
4.1% |
| Therapeutic Response Unexpected With Drug Substitution |
4.1% |
| Arrhythmia |
2.0% |
| Aspartate Aminotransferase Increased |
2.0% |
| Benign Intracranial Hypertension |
2.0% |
| Cardiovascular Disorder |
2.0% |
| Choreoathetosis |
2.0% |
| Convulsion |
2.0% |
| Drug Ineffective |
2.0% |
| Drug Prescribing Error |
2.0% |
| Electrocardiogram Qt Prolonged |
2.0% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
27.9% |
| Product Used For Unknown Indication |
20.7% |
| Anxiety |
15.3% |
| Major Depression |
8.1% |
| Depression |
4.5% |
| Obsessive-compulsive Disorder |
4.5% |
| Schizophrenia |
3.6% |
| Blood Pressure Abnormal |
1.8% |
| Contraception |
1.8% |
| Hypertension |
1.8% |
| Somnolence |
1.8% |
| Asthma |
0.9% |
| Bipolar I Disorder |
0.9% |
| Blood Triglycerides Increased |
0.9% |
| Constipation |
0.9% |
| Disturbance In Attention |
0.9% |
| Fluid Retention |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Immunisation |
0.9% |
| Menopause |
0.9% |
|
| Prescribed Overdose |
18.8% |
| Weight Decreased |
12.5% |
| Suicidal Ideation |
9.4% |
| Psychomotor Hyperactivity |
6.3% |
| Therapeutic Response Unexpected |
6.3% |
| Tic |
6.3% |
| Hyperthermia |
3.1% |
| Medication Error |
3.1% |
| Off Label Use |
3.1% |
| Poor Quality Drug Administered |
3.1% |
| Post-traumatic Stress Disorder |
3.1% |
| Product Quality Issue |
3.1% |
| Product Substitution Issue |
3.1% |
| Serotonin Syndrome |
3.1% |
| Suicide Attempt |
3.1% |
| Systemic Lupus Erythematosus |
3.1% |
| Urticaria |
3.1% |
| Violence-related Symptom |
3.1% |
| Weight Increased |
3.1% |
|
| Concomitant |
| Attention Deficit/hyperactivity Disorder |
20.1% |
| Product Used For Unknown Indication |
17.2% |
| Pain |
14.1% |
| Contraception |
7.3% |
| Anxiety |
6.3% |
| Depression |
5.7% |
| Multiple Sclerosis |
4.4% |
| Bipolar Disorder |
2.6% |
| Convulsion |
2.6% |
| Muscle Spasms |
2.6% |
| Hypertension |
2.3% |
| Contusion |
2.1% |
| Eczema |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Insomnia |
2.1% |
| Crohn's Disease |
1.8% |
| Headache |
1.3% |
| Migraine |
1.3% |
| Acne |
1.0% |
| Arthralgia |
1.0% |
|
| Pulmonary Embolism |
18.6% |
| Weight Increased |
11.9% |
| Drug Effect Decreased |
8.5% |
| Thrombosis |
6.8% |
| Injection Site Pain |
5.1% |
| Back Pain |
3.4% |
| Convulsion |
3.4% |
| Deep Vein Thrombosis |
3.4% |
| Pain |
3.4% |
| Pain In Extremity |
3.4% |
| Psychomotor Hyperactivity |
3.4% |
| Pulmonary Haemorrhage |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Suicidal Ideation |
3.4% |
| Treatment Noncompliance |
3.4% |
| Type 2 Diabetes Mellitus |
3.4% |
| Vaginal Haemorrhage |
3.4% |
| Vision Blurred |
3.4% |
| Vomiting |
3.4% |
| Abdominal Pain |
1.7% |
|
| Interacting |
| Anxiety |
25.0% |
| Attention Deficit/hyperactivity Disorder |
25.0% |
| Contraception |
25.0% |
| Ovarian Cyst |
25.0% |
|
| Loss Of Consciousness |
100.0% |
|
